Infections in Heart Failure - Impact on Mortality.
作者信息
Mesquita Evandro Tinoco
机构信息
Universidade Federal Fluminense, Niterói, RJ, Brazil.
出版信息
Arq Bras Cardiol. 2018 Apr;110(4):371-372. doi: 10.5935/abc.20180067.
Abstract
摘要
相似文献
1
Infections in Heart Failure - Impact on Mortality.心力衰竭中的感染——对死亡率的影响
Arq Bras Cardiol. 2018 Apr;110(4):371-372. doi: 10.5935/abc.20180067.
2
[Bidirectional impact of two chronic diseases: heart failure and diabetes mellitus].[两种慢性疾病的双向影响：心力衰竭和糖尿病]
Medwave. 2016 Dec 27;16(Suppl4):e6823. doi: 10.5867/medwave.2016.6823.
3
The Impact of Concomitant Diagnosis of Viral Infections on in-Hospital Mortality in Patients Hospitalized with a Diagnosis of Heart Failure in the United States: Insights from the National Inpatient Sample.美国因心力衰竭住院患者合并病毒感染对住院死亡率的影响：来自全国住院患者样本的见解。
Viruses. 2022 Oct 31;14(11):2418. doi: 10.3390/v14112418.
4
Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry.新诊断的急性心力衰竭入院后感染：来自 KCHF 登记处。
J Am Heart Assoc. 2021 Nov 16;10(22):e023256. doi: 10.1161/JAHA.121.023256. Epub 2021 Nov 3.
5
"Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure.复发性心脏事件对心力衰竭患者死亡率的“剂量依赖性”影响。
Am J Med. 2009 Feb;122(2):162-169.e1. doi: 10.1016/j.amjmed.2008.08.026. Epub 2008 Dec 26.
6
The Impact of Environmental Factors on the Mortality of Patients With Chronic Heart Failure.环境因素对慢性心力衰竭患者死亡率的影响。
Am J Cardiol. 2021 May 1;146:48-55. doi: 10.1016/j.amjcard.2021.01.019. Epub 2021 Feb 9.
7
Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012.院内心脏康复对心力衰竭患者死亡率和再入院率的影响：意大利伦巴第地区 2005 年至 2012 年的一项人群研究。
Eur J Prev Cardiol. 2019 May;26(8):808-817. doi: 10.1177/2047487319833512. Epub 2019 Feb 27.
8
Risk Factors for Acute Heart Failure and Impact on In-Hospital Mortality after Stroke.急性心力衰竭的危险因素及其对卒中后院内死亡率的影响。
J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1629-1635. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.030. Epub 2019 Mar 28.
9
Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study.糖尿病对急性心力衰竭患者死亡率的影响：一项前瞻性队列研究。
Cardiovasc Diabetol. 2020 May 2;19(1):49. doi: 10.1186/s12933-020-01026-3.
10
Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors.老年心力衰竭患者死亡率的决定因素：血管紧张素转换酶抑制剂的作用
Arch Intern Med. 1998 Oct 12;158(18):2024-8. doi: 10.1001/archinte.158.18.2024.
引用本文的文献
1
Antibiotic Resistance in the Elderly: Mechanisms, Risk Factors, and Solutions.老年人中的抗生素耐药性：机制、风险因素及解决方案
Microorganisms. 2024 Sep 30;12(10):1978. doi: 10.3390/microorganisms12101978.
2
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.达格列净和恩格列净在糖尿病或/和心力衰竭患者中的安全性：一项基于欧洲药物警戒数据库的回顾性药物警戒研究。
Pharmacol Rep. 2025 Feb;77(1):274-286. doi: 10.1007/s43440-024-00668-4. Epub 2024 Oct 23.
3
The Impact of Concomitant Diagnosis of Viral Infections on in-Hospital Mortality in Patients Hospitalized with a Diagnosis of Heart Failure in the United States: Insights from the National Inpatient Sample.美国因心力衰竭住院患者合并病毒感染对住院死亡率的影响：来自全国住院患者样本的见解。
Viruses. 2022 Oct 31;14(11):2418. doi: 10.3390/v14112418.
4
Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction.因疫苗可预防疾病而住院的心衰射血分数降低患者。
Clin Cardiol. 2022 May;45(5):474-481. doi: 10.1002/clc.23800. Epub 2022 Mar 10.
5
Lockdown Britain: Evidence for reduced incidence and severity of some non-COVID acute medical illnesses.英国封锁措施：一些非 COVID-19 急性内科疾病发病率和严重程度降低的证据。
Clin Med (Lond). 2021 Mar;21(2):e171-e178. doi: 10.7861/clinmed.2020-0586.
6
Anaerobic Bacteremias in Left Ventricular Assist Devices and Advanced Heart Failure.左心室辅助装置与晚期心力衰竭患者的厌氧菌血症
Case Rep Infect Dis. 2019 Dec 19;2019:7571606. doi: 10.1155/2019/7571606. eCollection 2019.
本文引用的文献
1
Infection in Patients with Decompensated Heart Failure: In-Hospital Mortality and Outcome.失代偿性心力衰竭患者的感染：住院死亡率及预后
Arq Bras Cardiol. 2018 Mar 12;110(4):364-370. doi: 10.5935/abc.20180037. Print 2018 Apr.
2
Prognostic and diagnostic value of elevated serum concentration of procalcitonin in patients with suspected heart failure. A review and meta-analysis.疑似心力衰竭患者血清降钙素原浓度升高的预后及诊断价值：一项综述与荟萃分析
Biomarkers. 2018 Jul;23(5):407-413. doi: 10.1080/1354750X.2018.1443511. Epub 2018 Mar 12.
3
Cardiovascular dysfunction in sepsis at the dawn of emerging mediators.脓毒症中新兴介质出现时的心血管功能障碍。
Biomed Pharmacother. 2017 Nov;95:153-160. doi: 10.1016/j.biopha.2017.08.066. Epub 2017 Sep 12.
4
Effect of precipitating factors of acute heart failure on readmission and long-term mortality.急性心力衰竭诱发因素对再入院率和长期死亡率的影响。
ESC Heart Fail. 2016 Jun;3(2):115-121. doi: 10.1002/ehf2.12083. Epub 2016 Jan 21.
5
Sepsis-induced myocardial dysfunction: pathophysiology and management.脓毒症相关性心肌功能障碍：病理生理学与治疗。
J Intensive Care. 2016 Mar 23;4:22. doi: 10.1186/s40560-016-0148-1. eCollection 2016.
6
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.基于降钙素原的细菌感染指征可识别高危急性心力衰竭患者。
Int J Cardiol. 2016 Feb 1;204:164-71. doi: 10.1016/j.ijcard.2015.11.141. Epub 2015 Nov 26.
7
Predictors and outcomes of infection-related hospital admissions of heart failure patients.心力衰竭患者感染相关性住院的预测因素和结局。
PLoS One. 2013 Aug 23;8(8):e72476. doi: 10.1371/journal.pone.0072476. eCollection 2013.
Zotero 插件